Marshall Financial Group (Maryland)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-477
Closed -$268K 325
2026
Q1
$268K Sell
477
-6
-1% -$3.85K 0.04% 254
2025
Q4
$327K Sell
483
-1,936
-80% -$1.32M 0.06% 234
2025
Q3
$1.55M Buy
2,419
+5
+0.2% +$3.04K 0.3% 79
2025
Q2
$1.32M Buy
2,414
+128
+6% +$61.2K 0.26% 82
2025
Q1
$960K Buy
2,286
+290
+15% +$126K 0.21% 115
2024
Q4
$825K Buy
1,996
+112
+6% +$49.1K 0.2% 129
2024
Q3
$952K Buy
1,884
+30
+2% +$14.6K 0.23% 122
2024
Q2
$903K Buy
1,854
+135
+8% +$67.8K 0.25% 105
2024
Q1
$928K Buy
1,719
+154
+10% +$84.2K 0.27% 103
2023
Q4
$869K Buy
1,565
+216
+16% +$101K 0.28% 100
2023
Q3
$590K Buy
1,349
+45
+3% +$22.4K 0.21% 117
2023
Q2
$655K Buy
1,304
+75
+6% +$35.9K 0.22% 113
2023
Q1
$615K Buy
+1,229
New +$588K 0.22% 122
2022
Q4
Sell
-1,728
Closed -$563K 184
2022
Q3
$563K Buy
1,728
+20
+1% +$7.35K 0.24% 126
2022
Q2
$599K Buy
1,708
+260
+18% +$106K 0.24% 129
2022
Q1
$792K Buy
1,448
+10
+0.7% +$5.26K 0.32% 114
2021
Q4
$947K Buy
1,438
+182
+14% +$114K 0.35% 106
2021
Q3
$781K Buy
1,256
+70
+6% +$47K 0.4% 87
2021
Q2
$749K Buy
+1,186
New +$655K 0.4% 78

Other funds holding IDXX

Marshall Financial Group (Maryland)'s IDXX Position: Q2 2026 in Review

Marshall Financial Group (Maryland) sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 477 shares — an estimated $268K sold.

Marshall Financial Group (Maryland) first reported a position in IDXX in Q2 2021 and held it in 19 quarters. The position peaked at $1.55M in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Marshall Financial Group (Maryland) reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Marshall Financial Group (Maryland) sold 477 Idexx Laboratories shares in Q2 2026, an estimated $268K.
  • Marshall Financial Group (Maryland) first reported a position in Idexx Laboratories in Q2 2021 and held it in 19 quarters.
  • Marshall Financial Group (Maryland)'s Idexx Laboratories position peaked at $1.55M in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q2 2026, filed 20 Jul 2026.